CN Patent

CN107793413B — 嘧啶杂环化合物及其制备方法和应用

Assigned to Shanghai Kezhou Pharmaceutical Co ltd · Expires 2021-09-28 · 5y expired

What this patent protects

本发明涉及式(I)的化合物及其药物学上可接受的盐、前药和溶剂化物，这类化合物可用于治疗哺乳动物中癌症和炎症。本发明还公开了式(I)化合物的制备方法以及包含所述化合物的药物组合物。

USPTO Abstract

本发明涉及式(I)的化合物及其药物学上可接受的盐、前药和溶剂化物，这类化合物可用于治疗哺乳动物中癌症和炎症。本发明还公开了式(I)化合物的制备方法以及包含所述化合物的药物组合物。

Drugs covered by this patent

mobocertinib-succinate (MOBOCERTINIB SUCCINATE)

Patent Metadata

Patent number: CN107793413B
Jurisdiction: CN
Classification: —
Expires: 2021-09-28
Drug substance claim: No
Drug product claim: No
Assignee: Shanghai Kezhou Pharmaceutical Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.